Latest SEC filings

MAIA Biotechnology CEO Vlad Vitoc purchased 73,000 common shares at $1.37 in an open-market transaction worth $100,010, not under a 10b5-1 plan.

• Bought 73,000 shares at $1.37 per share, a total of $100,010
• Transaction was an open-market purchase (code P), not made under a 10b5-1 trading plan

Director Ramiro Guerrero bought 37,595 shares of common stock for $49,516.37.

• Ramiro Guerrero, a Director, acquired shares.
• The purchase was for 37,595 shares at an average price of $1.32 per share.

Director Ramiro Guerrero bought 133,790 shares of common stock for a total of $184,103.30.

• Ramiro Guerrero, a Director, acquired shares through an open-market purchase.
• The total value of the transaction was $184,103.30.